Clinical trialNCT00359762CompletedPhase 3Interventional

Exenatide Versus Glimepiride in Patients With Type 2 Diabetes

SponsorAstraZenecaEnrollment1,029Type 2 Diabetes Mellitus

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

James Malone, MD
Eli Lilly and Company
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

114 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Austria

Research Site
Graz, Austria
Research Site
Innsbruck, Austria
Research Site
Salzburg, Austria
Research Site
Vienna, Austria

Czechia

Research Site
Beroun, Czechia
Research Site
Hradec Králové, Czechia
Research Site
Liberec, Czechia
Research Site
Prague, Czechia
Research Site
Písek, Czechia
Research Site
Třebíč, Czechia
Research Site
České Budějovice, Czechia

Finland

Research Site
Helsinki, Finland
Research Site
Kuopio, Finland
Research Site
Pori, Finland
Research Site
Vaasa, Finland

France

Research Site
Alençon, France
Research Site
Bois-Guillaume, France
Research Site
Bourg-des-Comptes, France
Research Site
Broglie, France
Research Site
Bron, France
Research Site
Fléville-devant-Nancy, France
Research Site
Le Creusot, France
Research Site
Le Mans, France
Research Site
Loudun, France
Research Site
Montigny-lès-Metz, France
Research Site
Nevers, France
Research Site
Strasbourg, France
Research Site
Thouars, France
Research Site
Tours, France
Research Site
Valréas, France
Research Site
Vihiers, France
Research Site
Vénissieux, France

Germany

Research Site
Altona, Germany
Research Site
Aschaffenburg, Germany
Research Site
Bad Staffelstein, Germany
Research Site
Dresden, Germany
Research Site
Eisenach, Germany
Research Site
Essen, Germany
Research Site
Essen Schonnebeck, Germany
Research Site
Falkensee, Germany

74 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2006
Primary completion: 31 Mar 2011
Completion: 31 Mar 2011
Last update posted: 15 Sept 2015
Registered enrollment: 1,029
Registry id: NCT00359762

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.